FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024897628> ?p ?o ?g. }

• W2024897628 endingPage "e15627" @default.
• W2024897628 startingPage "e15627" @default.
• W2024897628 abstract "Resveratrol (3, 4', 5 tri-hydroxystilbene), a naturally occurring polyphenol, exhibits anti-inflammatory, antioxidant, cardioprotective and antitumor activities. We have recently shown that resveratrol can enhance the apoptosis-inducing potential of TRAIL in prostate cancer cells through multiple mechanisms in vitro. Therefore, the present study was designed to validate whether resveratrol can enhance the apoptosis-inducing potential of TRAIL in a xenograft model of prostate cancer.Resveratrol and TRAIL alone inhibited growth of PC-3 xenografts in nude mice by inhibiting tumor cell proliferation (PCNA and Ki67 staining) and inducing apoptosis (TUNEL staining). The combination of resveratrol and TRAIL was more effective in inhibiting tumor growth than single agent alone. In xenografted tumors, resveratrol upregulated the expressions of TRAIL-R1/DR4, TRAIL-R2/DR5, Bax and p27(/KIP1), and inhibited the expression of Bcl-2 and cyclin D1. Treatment of mice with resveratrol and TRAIL alone inhibited angiogenesis (as demonstrated by reduced number of blood vessels, and VEGF and VEGFR2 positive cells) and markers of metastasis (MMP-2 and MMP-9). The combination of resveratrol with TRAIL further inhibited number of blood vessels in tumors, and circulating endothelial growth factor receptor 2-positive endothelial cells than single agent alone. Furthermore, resveratrol inhibited the cytoplasmic phosphorylation of FKHRL1 resulting in its enhanced activation as demonstrated by increased DNA binding activity.These data suggest that resveratrol can enhance the apoptosis-inducing potential of TRAIL by activating FKHRL1 and its target genes. The ability of resveratrol to inhibit tumor growth, metastasis and angiogenesis, and enhance the therapeutic potential of TRAIL suggests that resveratrol alone or in combination with TRAIL can be used for the management of prostate cancer." @default.
• W2024897628 created "2016-06-24" @default.
• W2024897628 creator A5000344564 @default.
• W2024897628 creator A5026194586 @default.
• W2024897628 creator A5038606074 @default.
• W2024897628 creator A5043999741 @default.
• W2024897628 creator A5045165942 @default.
• W2024897628 date "2010-12-28" @default.
• W2024897628 modified "2023-10-09" @default.
• W2024897628 title "Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor" @default.
• W2024897628 cites W1512761670 @default.
• W2024897628 cites W1555388156 @default.
• W2024897628 cites W1563658944 @default.
• W2024897628 cites W1896084487 @default.
• W2024897628 cites W1966011016 @default.
• W2024897628 cites W1977351943 @default.
• W2024897628 cites W1978691010 @default.
• W2024897628 cites W1980886592 @default.
• W2024897628 cites W1986896225 @default.
• W2024897628 cites W1992885568 @default.
• W2024897628 cites W1996200651 @default.
• W2024897628 cites W1998410775 @default.
• W2024897628 cites W1999134519 @default.
• W2024897628 cites W1999797961 @default.
• W2024897628 cites W2005867401 @default.
• W2024897628 cites W2006609360 @default.
• W2024897628 cites W2011785467 @default.
• W2024897628 cites W2016130239 @default.
• W2024897628 cites W2022391934 @default.
• W2024897628 cites W2024202249 @default.
• W2024897628 cites W2025457067 @default.
• W2024897628 cites W2030410762 @default.
• W2024897628 cites W2032498325 @default.
• W2024897628 cites W2034118572 @default.
• W2024897628 cites W2034201098 @default.
• W2024897628 cites W2035991083 @default.
• W2024897628 cites W2049312704 @default.
• W2024897628 cites W2049990134 @default.
• W2024897628 cites W2053058618 @default.
• W2024897628 cites W2054054828 @default.
• W2024897628 cites W2054775930 @default.
• W2024897628 cites W2062036842 @default.
• W2024897628 cites W2070124969 @default.
• W2024897628 cites W2071255032 @default.
• W2024897628 cites W2073300010 @default.
• W2024897628 cites W2079797384 @default.
• W2024897628 cites W2082409488 @default.
• W2024897628 cites W2087616494 @default.
• W2024897628 cites W2088858249 @default.
• W2024897628 cites W2088934129 @default.
• W2024897628 cites W2091028211 @default.
• W2024897628 cites W2091064045 @default.
• W2024897628 cites W2095554214 @default.
• W2024897628 cites W2097948853 @default.
• W2024897628 cites W2107782164 @default.
• W2024897628 cites W2124062217 @default.
• W2024897628 cites W2124261225 @default.
• W2024897628 cites W2124898423 @default.
• W2024897628 cites W2127891491 @default.
• W2024897628 cites W2129795601 @default.
• W2024897628 cites W2134199670 @default.
• W2024897628 cites W2137035181 @default.
• W2024897628 cites W2140523735 @default.
• W2024897628 cites W2145558487 @default.
• W2024897628 cites W2149475828 @default.
• W2024897628 cites W2155730420 @default.
• W2024897628 cites W2159394937 @default.
• W2024897628 cites W2167366196 @default.
• W2024897628 cites W2170810801 @default.
• W2024897628 doi "https://doi.org/10.1371/journal.pone.0015627" @default.
• W2024897628 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3011015" @default.
• W2024897628 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21209944" @default.
• W2024897628 hasPublicationYear "2010" @default.
• W2024897628 type Work @default.
• W2024897628 sameAs 2024897628 @default.
• W2024897628 citedByCount "111" @default.
• W2024897628 countsByYear W20248976282012 @default.
• W2024897628 countsByYear W20248976282013 @default.
• W2024897628 countsByYear W20248976282014 @default.
• W2024897628 countsByYear W20248976282015 @default.
• W2024897628 countsByYear W20248976282016 @default.
• W2024897628 countsByYear W20248976282017 @default.
• W2024897628 countsByYear W20248976282018 @default.
• W2024897628 countsByYear W20248976282019 @default.
• W2024897628 countsByYear W20248976282020 @default.
• W2024897628 countsByYear W20248976282021 @default.
• W2024897628 countsByYear W20248976282022 @default.
• W2024897628 countsByYear W20248976282023 @default.
• W2024897628 crossrefType "journal-article" @default.
• W2024897628 hasAuthorship W2024897628A5000344564 @default.
• W2024897628 hasAuthorship W2024897628A5026194586 @default.
• W2024897628 hasAuthorship W2024897628A5038606074 @default.
• W2024897628 hasAuthorship W2024897628A5043999741 @default.
• W2024897628 hasAuthorship W2024897628A5045165942 @default.
• W2024897628 hasBestOaLocation W20248976281 @default.
• W2024897628 hasConcept C121608353 @default.
• W2024897628 hasConcept C126322002 @default.
• W2024897628 hasConcept C167734588 @default.

• next